NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/23/2026
Back to search
Official data from USPTO
U UNI-QLEAVER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/24/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
09/02/2019
Registration date
10/20/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/20/2020
Last transaction
04/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Uppsala, SE
Examiner
CROWLEY, SEAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "UNI-QLEAVER" in blue and the design of an orange and light orange circle containing a white letter "U" inside of it.
Holders and representatives
Holders
QuiaPEG Pharmaceuticals AB
Representatives
Cynthia Johnson Walden Fish & Richardson P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; biological preparations for use in industry and science; Reagents for scientific and research useDiagnostic preparations for scientific or research use; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicalsphosphotriester linkers
Class 5
Pharmaceuticalsmedical and veterinary preparations for the treatment of cancercardiovascular diseaserespiratory disordersmetabolic disordersautoimmune diseaseneurologic and psychiatric disorders and infectious disease; pharmaceutical preparationsa drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; reagents for medical and veterinary uses; pharmaceutical substances being diagnosticpreparations and substances for medical purposes; diagnostic preparations for medical purposes; diagnostic reagentssubstances and contrast media for medical and veterinary purposes
Class 42
Scientific and technological servicesscientific researchanalysistesting and development in the field of pharmaceuticalsof pharmaceuticalmedical and veterinary preparationsreagents and substancesof diagnostic preparationsreagents and substances; PEGylation pharmaceuticals research services; industrial analysis and industrial research services in the field of pharmaceutical testing; product designtesting and development in the field of medical technology; information and advice regarding the aforementioned services
Publications
History of USPTO decisions and trademark events.
35 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/20/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/20/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/03/2021
FIMP
FINAL DISPOSITION PROCESSED
02/03/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/20/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/04/2020
PUBO
PUBLISHED FOR OPPOSITION
08/04/2020
GPNX
NOTIFICATION PROCESSED BY IB
07/31/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/15/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/15/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
07/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
07/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/01/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
05/26/2020
ALIE
ASSIGNED TO LIE
05/26/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/26/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
05/26/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/21/2020
RFNT
REFUSAL PROCESSED BY IB
01/17/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/01/2020
RFRR
REFUSAL PROCESSED BY MPU
12/31/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/06/2019
CNRT
NON-FINAL ACTION WRITTEN
12/05/2019
DOCK
ASSIGNED TO EXAMINER
12/04/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/15/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/14/2019
Continuous trademark protection
Get notified about every new filing that threatens U UNI-QLEAVER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.